Vertex, CRISPR strengthen case for pioneering gene-editing treatment
Positive data keep the companies’ therapy on track to become the first CRISPR-based treatment submitted to drug regulators.
CAR T-Cell Therapy Shows Early Promise for Gastrointestinal Cancer
A $100 genome? New DNA sequencers could be a ‘game changer’ for biology, medicine
The human microbiome: there is much left to do
It’s time to make the survey of humanity’s ‘second genome’ more complete.
Roche Alzheimer’s study fails in another setback to a long-tested hypothesis
The failure is an upset not only to Roche, but also a blow to the wider Alzheimer’s research field, which has for years kept focus on a protein called beta amyloid.
Cell-based and stem-cell-based treatments for spinal cord injury: evidence from clinical trials
Ancient DNA traces origin of Black Death
Genomes show that plague-causing bacteria found in Kyrgyzstan graves are direct ancestors of those that triggered the medieval pandemic.